Is Organogenesis Holdings, Inc. technically bullish or bearish?
2025-09-23 11:21:33As of 19 September 2025, the technical trend for Organogenesis Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators are bullish, while the monthly MACD and KST also support this stance. The Bollinger Bands indicate a bullish trend on the weekly chart and a mildly bullish trend on the monthly chart. However, the Dow Theory shows a mildly bearish signal on the weekly timeframe, contrasting with a mildly bullish monthly view. The daily moving averages are mildly bullish, suggesting some short-term strength. Overall, the indicators point to a mildly bullish stance, but the mixed signals, particularly from Dow Theory, indicate caution. Multi-period return data is not available for comparison with the S&P 500....
Read MoreIs Organogenesis Holdings, Inc. technically bullish or bearish?
2025-09-22 18:07:33As of 19 September 2025, the technical trend for Organogenesis Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD and KST indicators remain bullish, while the moving averages indicate a mildly bullish stance on the daily timeframe. However, the Dow Theory shows a mildly bearish signal on the weekly timeframe, which tempers the overall outlook. The Bollinger Bands are also mildly bullish on both weekly and monthly timeframes. In terms of performance, the stock has returned 43.12% year-to-date and 56.31% over the past year, significantly outperforming the S&P 500, which returned 13.31% and 16.64% in the same periods, respectively. Overall, the current technical stance is mildly bullish, supported by several indicators, despite some mixed signals....
Read MoreIs Organogenesis Holdings, Inc. technically bullish or bearish?
2025-09-20 20:06:13As of 6 August 2025, the technical trend for Organogenesis Holdings, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are bullish, supporting a positive momentum outlook. Daily moving averages also indicate a bullish stance. However, the Dow Theory shows a mixed signal with a weekly mildly bearish and monthly mildly bullish stance. The Bollinger Bands are mildly bullish on both weekly and monthly timeframes, while the KST and OBV are bullish on the monthly timeframe. In terms of performance, the stock has outperformed the S&P 500 year-to-date with a return of 48.44% compared to the S&P 500's 12.22%, and it has also shown a significant 66.67% return over the past year versus the S&P 500's 17.14%. Overall, the current technical stance is bullish, with strong indicators supporting this view....
Read MoreIs Organogenesis Holdings, Inc. overvalued or undervalued?
2025-09-20 18:38:58As of 8 May 2025, the valuation grade for Organogenesis Holdings, Inc. has moved from expensive to risky. Based on the current metrics, the company appears to be overvalued. The P/E ratio stands at 28, significantly higher than the industry average, while the EV to EBITDA ratio is 9.24. Additionally, the PEG ratio is notably low at 0.32, indicating potential overvaluation relative to growth expectations. In comparison to its peers, Organogenesis has a P/E ratio of 608.59, which is drastically higher than Castle Biosciences, Inc. at -71.36 and Orthofix Medical, Inc. at -4.76. This suggests that Organogenesis is trading at a premium compared to its risky peers. Furthermore, while the company has shown strong returns year-to-date at 48.44%, it has underperformed against the S&P 500 over the last three and five years, which returned 70.41% and 96.61%, respectively. This underperformance reinforces the notion t...
Read More





